In light of our observation of a strong association of circulating BCKA and hepatic BCKDK expression with NAFLD/NASH in people with severe obesity we aimed to determine whether another major lipogenic transcription factor, SREBP1 might also regulate hepatic BCKDK gene expression. Here, SREBF1 is linked to metabolic dysfunction-associated steatohepatitis.